Publications by authors named "Devin B Lowe"

Claim this Profile
A
A PD-L1/CD3 Bispecific Antibody Enhances the Antitumor Effects of Regorafenib against Colon Cancer.
Izuchukwu F Okpalanwaka, Elizabeth A Daugherity, Amanda L McCormick, Trevor S Anderson, Savanna L Smith, Devin B Lowe

Mol Cancer Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1.
Jennifer L Taylor, Kathleen M Kokolus, Per H Basse, Jessica N Filderman, Chloe E Cosgrove, Devin B Lowe

Vaccines (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling antibody drug conjugate potential using a granzyme B antibody fusion protein.
Trevor S Anderson, Amanda L McCormick, Savanna L Smith, Devin B Lowe

BMC Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection.
Trevor S Anderson, Amanda L McCormick, Elizabeth A Daugherity, Mariam Oladejo, Izuchukwu F Okpalanwaka, Devin B Lowe

Oncoimmunology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression.
Amanda L McCormick, Trevor S Anderson, Elizabeth A Daugherity, Izuchukwu F Okpalanwaka, Savanna L Smith, Devin B Lowe

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity.
Trevor S Anderson, Amanda L Wooster, Savanna L Piersall, Izuchukwu F Okpalanwaka, Devin B Lowe

Semin Cancer Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-drug conjugates: an evolving approach for melanoma treatment.
Trevor S Anderson, Amanda L Wooster, Ninh M La-Beck, Dipongkor Saha, Devin B Lowe

Melanoma Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell vaccine therapy for colorectal cancer.
Amanda L Wooster, Lydia H Girgis, Hayley Brazeale, Trevor S Anderson, Laurence M Wood, Devin B Lowe

Pharmacol Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenetic Features and Current Management of Glioblastoma.
Hong-My Nguyen, Kirsten Guz-Montgomery, Devin B Lowe, Dipongkor Saha

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-parametric flow cytometry staining procedure for analyzing tumor-infiltrating immune cells following oncolytic herpes simplex virus immunotherapy in intracranial glioblastoma.
Praveen K Bommareddy, Devin B Lowe, Howard L Kaufman, Samuel D Rabkin, Dipongkor Saha

J Biol Methods· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines.
Amanda L Wooster, Trevor S Anderson, Devin B Lowe

J Immunol Methods· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.
Devin B Lowe, Camille K Bivens, Alexis S Mobley, Christian E Herrera, Amanda L McCormick

MAbs· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy.
Ninh M La-Beck, Gary W Jean, Cindy Huynh, Saeed K Alzghari, Devin B Lowe

Pharmacotherapy· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring antigen-specific T cell responses using real-time PCR.
Devin B Lowe, Jennifer L Taylor, Walter J Storkus

Methods Mol Biol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology.
Jon A Weidanz, Krysten L Doll, Soumya Mohana-Sundaram, Timea Wichner, Devin B Lowe

J Vis Exp· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma.
Devin B Lowe, Anamika Bose, Jennifer L Taylor, Hussein Tawbi, Yan Lin

Oncoimmunology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.
Joel F Aldrich, Michael H Shearer, Devin B Lowe, Richard E Winn, Cynthia A Jumper

Cancer Immunol Immunother· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shock block for improved immunotherapy.
Aparna Rao, Devin B Lowe, Walter J Storkus

Oncoimmunology· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model.
Anamika Bose, Devin B Lowe, Aparna Rao, Walter J Storkus

Melanoma Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo.
Yanyan Qu, Lu Chen, Devin B Lowe, Walter J Storkus, Jennifer L Taylor

Mol Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice.
Xi Zhao, Anamika Bose, Hideo Komita, Jennifer L Taylor, Nina Chi, Devin B Lowe

J Immunol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic inflammation and immunologic-based constraints in malignant disease.
Devin B Lowe, Walter J Storkus

Immunotherapy· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.
Joel F Aldrich, Devin B Lowe, Michael H Shearer, Richard E Winn, Cynthia A Jumper

J Virol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigens.
Xi Zhao, Anamika Bose, Hideo Komita, Jennifer L Taylor, Mayumi Kawabe, Devin B Lowe

Mol Ther· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines and immunotherapeutics for the treatment of malignant disease.
Joel F Aldrich, Devin B Lowe, Michael H Shearer, Richard E Winn, Cynthia A Jumper

Clin Dev Immunol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis